FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 09:40:36 2024-05-15 EDT | ||
| 120.1 EUR | +2.58% |
|
| Current month | -14.91% | ||
| 1 month | +59.66% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-05-15 | 120.1 | +2.58% |
| 24-05-14 | 117 | +2.44% |
| 24-05-13 | 114.3 | -8.22% |
| 24-05-10 | 124.5 | -16.19% |
| 24-05-09 | 148.5 | -5.03% |
Delayed Quote Deutsche Boerse AG
Last update May 15, 2024 at 09:40 am
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SQ43TW |
| ISIN | DE000SQ43TW7 |
| Date issued | 2022-12-06 |
| Strike | 81.05 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.09 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 159.5 € |
|---|---|
| Lowest since issue | 9.52 € |
| Spread | 1.13 € |
| Spread % | 0.87% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
25
Last Close Price
44.71
USD
Average target price
53.19
USD
Spread / Average Target
+18.98%
- Stock Market
- Certificates
- Certificat
